![John W. Burns](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
John W. Burns
Geen lopende functies
Loopbaan van John W. Burns
Eerdere bekende functies van John W. Burns
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
Glycogenesys, Inc.
![]() Glycogenesys, Inc. Miscellaneous Commercial ServicesCommercial Services GlycoGenesys, Inc., a biotechnology company, develops novel pharmaceutical products based on carbohydrate compounds and related technologies. The company's lead drug candidate GCS-100, a treatment for various forms of solid tumors and bloodborne cancers, completed a Phase II (a) clinical trial for pancreatic cancer, and also completed a Phase II (a) clinical trial for colorectal cancer. The company focuses on the development of carbohydrate-based pharmaceutical products and related technologies in connection with oncology. It was founded in 1992 and is headquartered in Boston, MA. | Voorzitter | 01-01-2000 | - |
Financieel Directeur/CFO | 01-01-2000 | - | |
Treasurer | 01-01-2000 | - |
Opleiding van John W. Burns
New York University | Masters Business Admin |
Stevens Institute of Technology | Doctorate Degree |
Statistieken
Internationaal
Verenigde Staten | 4 |
Operationeel
Chairman | 1 |
Director of Finance/CFO | 1 |
Treasurer | 1 |
Sectoraal
Consumer Services | 3 |
Commercial Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Bedrijven in privébezit | 1 |
---|---|
Glycogenesys, Inc.
![]() Glycogenesys, Inc. Miscellaneous Commercial ServicesCommercial Services GlycoGenesys, Inc., a biotechnology company, develops novel pharmaceutical products based on carbohydrate compounds and related technologies. The company's lead drug candidate GCS-100, a treatment for various forms of solid tumors and bloodborne cancers, completed a Phase II (a) clinical trial for pancreatic cancer, and also completed a Phase II (a) clinical trial for colorectal cancer. The company focuses on the development of carbohydrate-based pharmaceutical products and related technologies in connection with oncology. It was founded in 1992 and is headquartered in Boston, MA. | Commercial Services |
- Beurs
- Insiders
- John W. Burns
- Ervaring